Alaunos Therapeutics | ZIOP - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Alaunos Therapeutics USD -1.19M 432K 2025-09
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Biogen USD 659.6M 192.2M 2025-09
Bioline Rx USD -2.21M 96K 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Curis USD -12.51M 40K 2024-06
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Incyte USD 383.88M 47.43M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
J&J USD 5.59B 1.81B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Knight Therapeutics CAD 2.94M 2.4M 2025-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Merck USD 6.24B 318M 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Novartis USD 4.5B 363M 2025-09
Organigram Holdings CAD -28.05M 7.76M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pfizer USD 4.65B 3.99B 2025-12
Pharma Mar EUR 43.61M 47.57M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
TG Therapeutics USD 50.49M 21.13M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Verastem USD -18.28M 9.78M 2024-06
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09